Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys

• Published in: Journal of controlled release 2023-07, Vol.359, p.384-399
• Main Authors: Sasaki, Keita, Fukakusa, Shota, Torikai, Yusuke, Suzuki, Chie, Sonohata, Ikumi, Kawahata, Takuto, Magata, Yasuhiro, Kawai, Keiichi, Haruta, Shunji
• Format: Article
• Language: English
• Subjects: 3D-printed nasal cast; [18F]Fallypride; absorption; Administration, Intranasal; Animals; bioadhesives; blood-brain barrier; Brain - metabolism; Combination delivery system; Cynomolgus monkeys; dextran; Domperidone - metabolism; Domperidone - pharmacology; dopamine receptors; Drug Delivery Systems - methods; drugs; epithelium; Humans; intravenous injection; liquids; Macaca fascicularis; medicine; nasal cavity; Nose-to-brain drug delivery; olfactory bulb; Olfactory region; permeability; Pharmaceutical Preparations - metabolism; positron-emission tomography; Powders; Texas; vaccination
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2023.06.005

The nose-to-brain (N2B) pathway has garnered attention because it transports drugs directly into the brain. Although recent studies have suggested the necessity of selective drug administration to the olfactory region for effective N2B drug delivery, the importance of delivering the formulation to the olfactory region and the detailed pathway involved in drug uptake in primates brain remain unclear. Here, we developed a combination system for N2B drug delivery comprising a proprietary mucoadhesive powder formulation and a dedicated nasal device (N2B-system) and evaluated it for nasal drug delivery to the brain in cynomolgus monkeys. This N2B-system demonstrated a much greater formulation distribution ratio in the olfactory region in an in vitro experiment using a 3D-printed nasal cast and in vivo experiment using cynomolgus monkeys, as compared to that in other nasal drug delivery systems that comprise of a proprietary nasal powder device developed for nasal absorption and vaccination and a commercially available liquid spray. Additionally, Texas Red-labeled dextran (TR-DEX, 3 kDa) was administered using the N2B-system to estimate the drug transition pathway from the nasal cavity to the brain. TR-DEX preferentially localized to the olfactory epithelium and reached the olfactory bulb through the cribriform foramina. Moreover, domperidone, a model drug with poor blood-brain barrier permeability, was administered to assess the brain uptake of medicine after olfactory region-selective administration by using the N2B-system. Domperidone accumulation in the brain was evaluated using positron emission tomography with intravenously administered [18F]fallypride based on competitive inhibition of the dopamine D2 receptor (D2R). Compared to other systems, the N2B-system significantly increased D2R occupancy and domperidone uptake in the D2R-expressing brain regions. The current study reveals that the olfactory region of the nasal cavity is a suitable target for efficient nasal drug delivery to the brain in cynomolgus monkeys. Thus, the N2B-system, which targets the olfactory region, provides an efficient approach for developing effective technology for nasal drug delivery to the brain in humans. [Display omitted] •An effective combination system for nose-to-brain (N2B) drug delivery was developed.•Monkeys were tested for N2B-system due to their similarity in human nasal anatomy.•N2B-system achieved efficient formulation delivery to the olfactory region.•Olfactory reg